Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1932 of 5804
-
Fat's secret messengers: could exosomes explain why some obese people stay healthy?
Knowledge-focused Recruiting nowThe goals of this research study are to: 1) understand why some people with obesity are protected from developing conditions such as type 2 diabetes and cardiovascular disease while others are more likely to develop obesity-related conditions; 2) assess the effect of small extrac…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
Experimental PSP drug shows promise in early trial
Disease control CompletedThe study will be conducted by the Sponsor to evaluate the efficacy and safety of GV1001 (0.56 mg and 1.12 mg) administered subcutaneously as a treatment for Progressive Supranuclear Palsy, (PSP). In 75 patients diagnosed with PSPR Richardson(PSP-RS) or PSP-Parkinsonism (PSP-P) a…
Phase: PHASE2 • Sponsor: GemVax & Kael • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Stool test vs. colonoscopy: which is better for older adults with polyps?
Diagnosis Recruiting nowThis is a multi-site comparative effectiveness randomized controlled trial (RCT) comparing annual fecal immunochemical testing (FIT) and colonoscopy for post-polypectomy surveillance among adults aged 65-82 with a history of colorectal polyps who are due for surveillance colonosc…
Phase: NA • Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Diagnosis
Last updated Jul 16, 2026 00:00 UTC
-
Heat therapy for pancreatic cancer: a new hope?
Disease control Recruiting nowThe purpose of the study is to evaluate the oncological efficacy of pancreatic radiofrequency by the objective response rate (complete and partial responses according to RECIST 1.1.), 5 years after the end of treatment.
Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New antibody injection aims to tackle blinding eye diseases
Disease control CompletedEYE103-101 is a 2-part study assessing safety and preliminary efficacy of EYE103 in patients with diabetic macular edema (DME) given as monotherapy or neovascular macular degeneration (NVAMD) given in combination with anti-VEGF. In the first part, termed the multiple ascending d…
Phase: PHASE1, PHASE2 • Sponsor: EyeBiotech Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New study tracks cancer risk in rare genetic condition
Knowledge-focused TerminatedThis is a multicentric, observational, retrospective and prospective study, aiming to estimate the risk of cancer occurrence in subjects carrying a PTEN mutation, based on the constitution of a national cohort.
Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Blood test may help doctors switch cancer treatment earlier
Knowledge-focused OngoingThe majority of patients (pts) with breast cancer have hormone receptor positive (HR+) disease, and this holds true for pts with advanced breast cancer (ABC). Currently frontline therapy for pts with HR+ ABC is antihormonal therapy with an aromatase inhibitor or selective estroge…
Phase: PHASE2 • Sponsor: University of Miami • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
New study tracks how well a targeted lung cancer drug works in everyday clinics
Disease control Recruiting nowThis is an open label, prospective, multicenter, non-comparative study to assess the safety and effectiveness of Tabrecta® (Capmatinib) in real world setting. Also, this study is to fulfill the regulatory requirements as part of the RMP (Risk Management Plan) for Tabrecta® (Capma…
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Massive Alzheimer's study aims to unlock secrets of memory loss
Knowledge-focused ENROLLING_BY_INVITATIONThe Alzheimer's Disease Neuroimaging Initiative 4 (ADNI4) is a non-randomized, longitudinal, natural history study designed to validate biomarkers, improve clinical trial design, and advance understanding of Alzheimer's disease across the full disease spectrum. Building on the su…
Sponsor: University of Southern California • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC
-
Breast milk may speed up feeding in newborns with gut defects
Disease control Recruiting nowThis study explores the use of an exclusive human milk diet versus standard feeding practices to compare the influence on feeding outcomes and the gut bacteria in infants with intestinal differences.
Phase: NA • Sponsor: Seattle Children's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Oral chemotherapy candidate utidelone moves to human testing for advanced cancers
Disease control OngoingThis study has three parts. Part 1 is a dose-escalation trial, Part 2 is a pharmacokinetic comparison and food effect study, and Part 3 is extended trial of combination of utidelone capsule and capecitabine. The primary objectives are 1. To evaluate the safety and tolerability of…
Phase: PHASE1 • Sponsor: Beijing Biostar Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New dressing aims to heal stubborn diabetic foot sores
Disease control CompletedThe study will evaluate the safety and performance of Symphony™ versus Standard of Care (SOC) in the treatment of chronic non-healing diabetic foot ulcers (DFU) after 12 weeks of treatment.
Phase: NA • Sponsor: Aroa Biosurgery Limited • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New digital tool aims to keep seniors on their feet
Prevention CompletedThe objectives of this proposal are to evaluate the eSTEPS CDS (eSTEPS) in a cluster randomized controlled trial. The intervention includes the following: 1) A machine learning-based fall injury risk screening algorithm to improve traditional fall risk screening. 2) Provider BPA …
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Prevention
Last updated Jul 10, 2026 00:00 UTC
-
New study tests if exercise and alendronate can save bones while shedding pounds
Disease control Recruiting nowThe purpose of this research is to identify strategies that minimize bone loss that occurs when older adults lose weight. Participation in this research will involve up to nine assessment visits and last up to two years.
Phase: PHASE4 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Experimental combo aims to rev up immune system against Hard-to-Treat prostate cancer
Disease control TerminatedThis phase II trial tests whether vidutolimod with nivolumab works to destroy tumor cells in patients with castration resistant prostate cancer that has spread to other places in the body (metastatic). Nivolumab is an antibody working by attaching to and blocking a molecule calle…
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 26, 2026 19:13 UTC
-
New nanobody drug shows promise for painful skin condition
Disease control CompletedThis was a Phase 2 study in adult participants with moderate to severe hidradenitis suppurativa (HS). The purpose of the study was to evaluate the efficacy and safety of SAR442970 compared to placebo.
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Could less be more? shorter antibiotic course after appendix surgery put to the test
Disease control TerminatedThe purpose of this study is to demonstrate the safety, efficacy, and feasibility of short-course post-operative antibiotic treatment for simple and complicated appendicitis
Phase: PHASE4 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Coin-Sized implant zaps nerves to curb urgent bathroom trips
Symptom relief CompletedThe goal of this prospective, multi-center, double-blinded randomized controlled is to learn about effectiveness and QOL with eCoin at two different amplitude settings in subjects with urge urinary incontincence (UUI). The main question it aims to answer is: * The reduction in U…
Phase: NA • Sponsor: Valencia Technologies Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Could a better medication review keep older adults out of the hospital?
Disease control CompletedThe goal of this cluster randomized controlled trial is to compare transitional multidisciplinary pharmacotherapeutic care (TMPC) with usual care in patients aged 70 years or older with polypharmacy, admitted to the hospital via the emergency department for longer than 24 hours a…
Phase: NA • Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New Antibody-Drug combo targets Hard-to-Treat cancers
Disease control Recruiting nowThis research is designed to determine if experimental treatment with Antibody-drug conjugate, AZD5335, alone, or in combination with anti-cancer agents is safe, tolerable, and has anti-cancer activity in patients with advanced tumors
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC